Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07212803 · ClinicalTrials.gov registry record · Phase 4
Effects of Energy Drinks on Cardiovascular Endpoints
A Phase 4 study of Healthy Volunteers and Safety After Oral Intake, sponsored by University of the Pacific.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT07212803: Recruiting Phase 4 study of Healthy Volunteers and Safety After Oral Intake, sponsored by University of the Pacific.
NCT07212803 is a Phase 4 study of Healthy Volunteers and Safety After Oral Intake that is actively recruiting participants, run by University of the Pacific. The registered enrollment target is 3 participants, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07212803, a Phase 4 study of Healthy Volunteers and Safety After Oral Intake, is actively recruiting participants, sponsored by University of the Pacific.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a clinical trial looking at the impact of energy drinks on heart related parameters. The study will enroll 3 participants who will be exposed to 8 different interventions.
Primary Outcome
QTc interval will be calculated using both Bazett's and Fridericia's correction formulas assessed via 12-lead ECG.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Energy Drink A + Placebo Capsule
- DRUG Placebo Drink + Moxifloxacin Capsule
- DIETARY_SUPPLEMENT Placebo Drink + Caffeine Capsule
- OTHER Placebo Drink + Placebo Capsule
- DIETARY_SUPPLEMENT Energy Drink B
Study Locations (1)
California
- University of the Pacific - Stockton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2026-09 |
| Phase | Phase 4 |
What NCT07212803 shows while recruiting
NCT07212803 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 482-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Healthy Volunteers appearing as the primary indexed condition, and to 5 interventions - of which Energy Drink A + Placebo Capsule is the first listed.
NCT07212803 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07212803 about?
NCT07212803 is a clinical study titled "Effects of Energy Drinks on Cardiovascular Endpoints". This is a clinical trial looking at the impact of energy drinks on heart related parameters. The study will enroll 3 participants who will be exposed to 8 different interventions.
What is the current status of trial NCT07212803?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2025-11-01. Estimated completion is 2026-09.
What conditions does trial NCT07212803 study?
This clinical trial studies the following conditions: Healthy Volunteers, Safety After Oral Intake.
What interventions are being tested in trial NCT07212803?
The interventions under investigation include: Energy Drink A + Placebo Capsule (DIETARY_SUPPLEMENT), Placebo Drink + Moxifloxacin Capsule (DRUG), Placebo Drink + Caffeine Capsule (DIETARY_SUPPLEMENT), Placebo Drink + Placebo Capsule (OTHER), Energy Drink B (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07212803?
This trial is sponsored by University of the Pacific, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07212803 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07212803's enrollment target sits among peer trials
3 284th of 283 the lowest of 283 other Healthy Volunteers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Volunteers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
KarXT Concentrations in the Breast Milk and Plasma of Lactating Females
RECRUITING · Phase 4
-
Investigation of the Gut Microbiome and Statin Response
ACTIVE NOT RECRUITING · Phase 4
-
Thorough QT Study of Nelfinavir
COMPLETED · Phase 4
-
A Study to Investigate Cardiac Troponin Levels After mRNA-1273.712 Vaccine in Participants 12 Through 30 Years of Age
COMPLETED · Phase 4
-
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
COMPLETED · Phase 4
-
Adaptive Optics Retinal Imaging
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI